Plus Tiered News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Plus Tiered. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Plus Tiered Today - Breaking & Trending Today

Karyopharm and Menarini Group Enter into Exclusive License Agreement to Commercialize NEXPOVIO® (selinexor) in Europe and Other Key Global Territories

Published: December 21, 2021

- Menarini Group Obtains Exclusive Rights to Commercialize NEXPOVIO for the Treatment of Hematologic and Solid Tumor Oncology Indications in Europe

Source: adnkronos.com

Related Topics:

United StatesUnited KingdomRichard PaulsonElcin Barker ErgunSelective Inhibitor Of Nuclear ExportKaryopharm Therapeutics IncMenarini Group Obtains Exclusive Rights To CommercializeEuropean CommissionDrug AdministrationPrnewswire Karyopharm Therapeutics IncExchange CommissionEuropean UnionMenarini GroupKaryopharm Selective Inhibitor Of Nuclear ExportEuropean Medicines AgencyCommittee For Medicinal Products Human UseGroup Obtains Exclusive RightsSolid Tumor Oncology IndicationsLatin AmericaFuture MilestonesPlus TieredDouble Digit RoyaltiesNet SalesSelective InhibitorNuclear Export